Cargando…
Clinical use of exhaled biomarkers in COPD
Exhaled breath analysis holds great promise as a diagnostic and investigative tool in COPD and is a new and rapidly expanding field of research in pulmonary disease. Generally speaking, exhaled breath analysis focuses on two areas: measurement of exhaled nitric oxide (ENO) and the detection of bioma...
Autores principales: | O’Reilly, Philip, Bailey, William |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699977/ https://www.ncbi.nlm.nih.gov/pubmed/18268915 |
Ejemplares similares
-
Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities
por: Malerba, Mario, et al.
Publicado: (2014) -
Reproducibility of exhaled biomarkers in COPD—the road less traveled
por: Horvath, Ildiko
Publicado: (2007) -
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
por: Turner, Steve W., et al.
Publicado: (2019) -
Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation
por: Antus, Balazs, et al.
Publicado: (2022) -
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
por: O'Reilly, Philip, et al.
Publicado: (2009)